Stifel Financial (NYSE:SF) strengthens its lead in the race to buy Morgan Keegan, with a book value of $1.5B. SF is entering into an exclusive negotiation with parent company Regions Financial (NYSE:RF), Bloomberg reports. The latest talks for the brokerage come after Regions dropped discussions with two P-E consortia.
AMAG Pharmaceuticals (NASDAQ:AMAG) is exploring a potential sale of the company. They hired Jefferies as a strategic advisor to “explore all opportunities to enhance stockholder value.
Don’t Miss: Angie’s List to Bask in Groupon’s Glow.
ACCO Brands (NYSE:ABD), in a transaction valued at ~$860M will merge with MeadWestvaco’s (NYSE:MWV) consumer and office products. MWV shareholders will own 50.5% of the combined company. ACCO says the combination will increase its annual revenues by more than 50%.
Valpey – Fisher (NASDAQ:VPF) has struck a deal with CTS to sell out. Currently VPF sits at $4.15/share, while CTS closed yesterday at $2.55/share.
ModusLink Global Solutions (NASDAQ:MLNK) is up after it says it is exploring strategic alternatives aimed at enhancing stockholder value. Goldman Sachs (NYSE:GS) will undertake a comprehensive review of viable alternatives, including a possible sale of certain assets.
Medtronic (NYSE:MDT) will sell its Physio-Control unit to Bain Capital for $487M in cash. Without specifying exactly how, Medtronic says it expects to use some of the proceeds to offset any dilutive EPS impact from the deal. The Physio-Control unit provides emergency medical response equipment.
Investing Insights: Congress Loves These 50 Stocks.